1 Abstract
Menstrual hygiene management (MHM) forms a critical component of ensuring access to adequate and equitable sanitation for all, as outlined in SDG 6.2. Despite its importance, little is known about MHM in Malawi, particularly at a household level. Through a household survey of MHM within 2 districts, we evaluated the type of menstrual absorbents used by people who menstruate. Reusable cloths/rags were the most used menstrual absorbent, used by 79.5% of respondents, whilst disposable absorbents, such as tampons and sanitary pads, were used by 18.6% of respondents. Appropriate MHM also incorporates adequate management of MHM materials, including the washing and drying of reusable menstrual absorbents. We evaluated the cleaning of reusable menstrual absorbents; most respondents (90.1%) reported appropriate washing of menstrual absorbents using soap and water, however only 20.3% reported that menstrual absorbents were dried outside in the sun (as is best practise) with most reporting that reusable menstrual absorbents were dried inside their homes. Our findings highlight the need for improved MHM within Malawi, not only in the access and affordability of appropriate menstrual absorbents but also the promotion of appropriate washing and drying of menstrual absorbents.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the Scottish Government under the Scottish Government Climate Justice Fund Water Futures Programme research grant HN-CJF-03 awarded to the University of Strathclyde (R.M. Kalin). Funding was also received from the Scottish Government for the joint PhD studentship of R.G.K Hinton between the James Hutton Institute and the University of Strathclyde. The data collection process was funded by CARE with the financial support of the Government of Canada provided through Global Affairs Canada.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consent was obtained from all subjects involved in the study. All data collected was in line with the Government of Malawi ethics and was agreed with each participant.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
Robert.Kalin{at}strath.ac.uk (R.M.K.)
kit.macleod{at}hutton.ac.uk (C.J.A.M.); mads.troldborg{at}hutton.ac.uk (M.T.)
laurentcharles.tremblaylevesque{at}gwp.org (L.C.T.L)
modesta.banda{at}gmail.com M.K.))
Data Availability
Confidential data were provided by the Government of Malawi and CARE. All data summarised is provided here.
